ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

PALI vs CGEN // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

Palisade Bio Inc. (NASDAQ) VS. Compugen Ltd. (NASDAQ) • 15-METRIC TALLY: PALI 1 — CGEN 4
■ METRIC PARITY
options-implied-move
—
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PALI VS. CGEN) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC PALI CGEN SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 87.30% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 85.00% -120.00 CGEN /roic <GO>
EV/EBITDA & P/E Valuation — 3.2x — TIE /valuation <GO>
Free Cash Flow Yield -5.23% 16.24% -21.47 CGEN /fcf-yield <GO>
Operating Margin — 43.10% — TIE /operating-margins <GO>
Net Profit Margin — 48.60% — TIE /net-margins <GO>
Revenue Growth (YoY) — 161.10% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 7/9 -5.00 CGEN /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 30.1 41.1 -11.00 CGEN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 4.6x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $207.4M $193.0M $14.4M PALI /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR PALI REV CGEN REV PALI GROSS % CGEN GROSS % PALI FCF CGEN FCF
FY 2025 $0 $72.8M — 87.3% -$10.8M $31.3M
FY 2024 $0 $27.9M — 71.5% -$12.2M $49.5M
FY 2023 $250.0K $33.5M — — -$11.1M -$35.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PALI // BETA —
CGEN // BETA —